← Back to Search

Supportive Care for Arthritis (RAISE Trial)

N/A
Recruiting
Led By Candace H Feldman, MD, MPH, ScD
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up -12 months through +12 months
Awards & highlights

RAISE Trial Summary

This trial tests whether providing tailored lists of resources and/or a specialized nurse navigator to patients with inflammatory arthritis and SDoH-related needs can reduce missed appointments and improve health outcomes.

Who is the study for?
This trial is for adults over 18 with arthritis-related rheumatic conditions who missed at least one clinic visit in the past year and have social needs, except unemployment or education. They must be getting care at specific hospitals, speak English or Spanish, and not be enrolled in certain other care programs.Check my eligibility
What is being tested?
The study tests three support strategies for patients with systemic rheumatic conditions: a tailored resource list (Arm 1), help from a community specialist (Arm 2), and assistance from a nurse navigator trained in these conditions working with the community specialist (Arm 3).See study design
What are the potential side effects?
Since this trial involves non-medical interventions like providing resources and personal guidance rather than drugs or medical procedures, traditional side effects are not expected. However, there may be indirect effects on patients' well-being based on their experiences.

RAISE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~-12 months through +12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and -12 months through +12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient no-shows
Secondary outcome measures
Acute care use for avoidable conditions
Acute care use overall
Disability metric
+14 more

RAISE Trial Design

3Treatment groups
Experimental Treatment
Group I: Arm 3Experimental Treatment1 Intervention
Arm 3 will receive the assistance of a bilingual (English and Spanish) nurse patient navigator with nursing training and additional rheumatology-specific training.
Group II: Arm 2Experimental Treatment1 Intervention
Arm 2 will receive the assistance of a community resource specialist (CRS)- an individual without formal medical training with community-based expertise.
Group III: Arm 1Experimental Treatment1 Intervention
Arm 1 is the control arm which will receive the standard of care resource sheets.

Find a Location

Who is running the clinical trial?

Bristol-Myers Squibb FoundationUNKNOWN
5 Previous Clinical Trials
1,246 Total Patients Enrolled
Brigham and Women's HospitalLead Sponsor
1,615 Previous Clinical Trials
11,470,572 Total Patients Enrolled
Bristol-Myers SquibbIndustry Sponsor
2,641 Previous Clinical Trials
4,129,806 Total Patients Enrolled
8 Trials studying Sjogren's Syndrome
1,388 Patients Enrolled for Sjogren's Syndrome

Media Library

Community Resource Specialist Clinical Trial Eligibility Overview. Trial Name: NCT05715463 — N/A
Sjogren's Syndrome Research Study Groups: Arm 1, Arm 2, Arm 3
Sjogren's Syndrome Clinical Trial 2023: Community Resource Specialist Highlights & Side Effects. Trial Name: NCT05715463 — N/A
Community Resource Specialist 2023 Treatment Timeline for Medical Study. Trial Name: NCT05715463 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals over 45 eligible for participation in this experiment?

"According to the official guidelines for this trial, individuals aged 18-100 are eligible to enroll as participants."

Answered by AI

How many individuals have registered to partake in this research?

"Affirmative. Clinicaltrials.gov data reveals that this medical project, which was originally introduced on February 28th 2023 is presently recruiting participants to take part in the trial. 258 individuals must be recruited from one site for the study to be completed successfully."

Answered by AI

Does this clinical trial still have open slots for volunteers?

"Absolutely, according to clinicaltrials.gov this medical trial is accepting participants at the current time. The trial was initially posted on February 28th 2023 and updated most recently on February 22nd 2023. 258 patients are required from a single site for enrollment in this study."

Answered by AI

What demographic is best suited to participate in this experiment?

"For this clinical trial, 258 participants with a confirmed diagnosis of rheumatoid arthritis, aged 18 years and above are being recruited. Notably, they need to be able to communicate in either English or Spanish language; have missed an appointment at a health care provider within the past year; express one or more social determinants of health needs on the Mass General Brigham questionnaire (except for unemployment and education); and receive their current medical treatment from either Faulkner Hospital or Brigham and Women's Hospital clinics."

Answered by AI

Who else is applying?

What site did they apply to?
Brigham & Women's Hospital
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity
Candace Hillary Feldman, MD 2023. "Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05715463.
All > Scleroderma Research Foundation > Sjogrens Syndrome
~172 spots leftby Dec 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top